# Vistapath Biosystems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vistapath-biosystems

- Industry: Software
- Headquarters: Cambridge, US
- Website: www.vistapathbio.com
- Total disclosed funding: $4M
- Latest round: Seed (Jun 30, 2022)
- Investors on record: 3

## About

Based in Massachusetts, US, and founded in 2017, Vistapath Biosystems, Inc. operates as a developer of a data-driven pathology processing platform for hospitals, CROs (contract research organizations), hospitals, and life sciences. In June 2022, the firm raised USD 4 million in seed funding led by investor Moxxie Ventures, with participation from other investors First Star Ventures and NextGen Venture Partners. 

The company offers grossing solutions using computer vision and artificial intelligence (AI), enabling pathologists, clinicians, and anatomical pathologists to automate samples for diagnosis, the process of inspecting, inking, and measuring tissues enable. The company’s platform can be integrated with the lab’s existing workflow and assess specimens and create a gross report 93% faster with 43% more accuracy.

The company plans to utilize its June 2022 funding to scale the development of its products and expand its operational and technical capabilities.

## Funding rounds

- Seed, Jun 30, 2022, $4M — First Star Ventures, NextGen Venture Partners, Moxxie Ventures

## Investors

- First Star Ventures (https://capitalatlas.ai/funds/first-star-ventures) — Seed
- NextGen Venture Partners (https://capitalatlas.ai/funds/nextgen-venture-partners) — Seed
- Moxxie Ventures (https://capitalatlas.ai/funds/moxxie-ventures) — Seed